RE:RE:RE:RE:RE:Damn lost the FDA Trifecta this week.Viewing the situation from far outside any inner circle, I find nothing at all sinister about the departure of a one of two co-CEOs ... I've often seen two chosen to vie for the top job within a corporation, and nearly as often the victor went on to assume dual duties and the vanquished moved on to another situation.